Jupiter Neurosciences, Inc.
JUNS
$1.11
-$0.13-10.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.09% | -158.48% | -288.76% | 149.38% | -47.60% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 127.99% | 1,558.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | -61.95% | 498.11% | 128.51% | -283.99% | 620.41% |
| Change in Net Operating Assets | 95.69% | -1,037.66% | 59.98% | 6.16% | -1.68% |
| Cash from Operations | 71.24% | -8,575.59% | 60.37% | -64.88% | 59.53% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -94.64% | -56.25% | 42.22% | -65.38% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 26,560.71% | -75.44% | 153.33% | -65.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -128.20% | 25,917.12% | -324.62% | 132.18% | 35.05% |